KRYSTAL-1: Activity and Safety of Adagrasib (MRTX849) in Patients with Colorectal Cancer (CRC) and Other Solid Tumors Harboring a KRAS G12C Mutation
Melissa L. Johnson, S.-H.I. Ou, Minal Barve, Igor I. Rybkin, Kyriakos P. Papadopoulos, Ticiana Leal, Karen Velastegui, James G. Christensen, Thian Kheoh, Richard C. Chao, J. Weiß
Topics & Concepts
KRASColorectal cancerCancer researchMutationCancerAdenocarcinomaMedicineBiologyInternal medicineGeneticsGeneColorectal Cancer Treatments and StudiesCancer Treatment and PharmacologyPI3K/AKT/mTOR signaling in cancer